Comparing cardiometabolic monitoring and side effect management in a pharmacist-led ambulatory clozapine clinic versus standard care.

Authors

Nicholas Buttermore PharmD, Parkview HealthFollow
Jenna Gilbert PharmD, BCPPFollow
Naana Boachie PharmD, BCACP, Parkview HealthFollow
Kenneth Wiley PharmD, BCACP, Parkview HealthFollow
Sarah Ferrell PharmD, BCPPS, Parkview HealthFollow

Abstract

Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA

This study found that cardiometabolic monitoring rates were significantly higher in the pharmacist group compared to standard care, and that clozapine-related side effects were screened more frequently.

Document Type

Poster

Publication Date

12-2024

Recommended Citation

Buttermore, Nicholas PharmD; Gilbert, Jenna PharmD, BCPP; Boachie, Naana PharmD, BCACP; Wiley, Kenneth PharmD, BCACP; and Ferrell, Sarah PharmD, BCPPS, "Comparing cardiometabolic monitoring and side effect management in a pharmacist-led ambulatory clozapine clinic versus standard care." (2024). Pharmacy Residency. 40.
https://researchrepository.parkviewhealth.org/pharmresidency/40